Etoricoxib-Cannabidiol Combo: Potential Role in Glioblastoma Treatment and Development of PLGA-Based Nanoparticles

Etoricoxib-Cannabidiol Combo: Potential Role in Glioblastoma Treatment and Development of PLGA-Based Nanoparticles

Background: Glioblastoma (GBM) is the most frequently occurring primary malignant central nervous system tumor, with a poor prognosis and median survival below two years. Administration of a combination of non-steroidal anti-inflammatory drugs and natural compounds that exhibit a curative or prophyl...

Full description

Bibliographic Details
Main Authors: Joanna Kuźmińska, Agnieszka Sobczak, Aleksandra Majchrzak-Celińska, Izabela Żółnowska, Aleksandra Gostyńska, Barbara Jadach, Violetta Krajka-Kuźniak, Anna Jelińska, Maciej Stawny
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Pharmaceutics
Subjects:
etoricoxib
cannabidiol
glioblastoma
PLGA
nanocarriers
drug nanoformulations
Online Access:https://www.mdpi.com/1999-4923/15/8/2104

Internet

https://www.mdpi.com/1999-4923/15/8/2104

Similar Items